Acetylcholine receptor and behavioral deficits in mice lacking apolipoprotein E

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Apolipoprotein E (apoE) is linked to Alzheimer's disease (AD) risk.
• Impaired central acetylcholine (ACh) function is a key feature of AD.
• ApoE may influence ACh function by modulating muscarinic ACh receptors (mAChRs).

Purpose of the Study:

• To investigate the role of apoE in modulating muscarinic ACh receptor (mAChR) function.
• To determine if apoE influences cognitive tasks dependent on ACh transmission.
• To assess the impact of apoE deficiency on central mAChR function and behavioral responses.

Main Methods:

• Compared mAChR binding in apoE-null mice and wild-type (WT) controls.
• Assessed cognitive performance using pre-pulse inhibition, delay eyeblink conditioning, and 5-choice serial reaction time task (5-SRTT).
• Challenged central mAChR function with scopolamine administration.

Main Results:

• Mice lacking apoE exhibited reduced cortical and hippocampal mAChRs compared to WT mice.
• Scopolamine significantly impaired delay eyeblink conditioning in apoE-null mice but not WT mice.
• ApoE-null mice failed to acquire performance on the 5-SRTT, indicating significant cognitive deficits.

Conclusions:

• ApoE plays a crucial role in regulating central mAChR expression and function.
• Deficits in apoE function may lead to cholinergic impairments contributing to cognitive decline in AD.
• Modulation of cortical and hippocampal mAChRs by apoE is implicated in cognitive performance and drug sensitivity.